Leitlinie
WHO Guideline on GLP-1 Therapies for Treatment of Obesity in Adults
JAMA · 28.04.2026 · 335 (16) · 1450
DOI: 10.1001/jama.2026.0678 ↗Kurz gefasst
Leitlinie in der Zeitschrift JAMA, erschienen am 28.04.2026. Verfasst von Mohammad Kazem Fallahzadeh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section of Nephrology, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Section of Nephrology, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
- Division of Nephrology, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, Missouri.
- Division of Nephrology, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
Zitieren
APA
Fallahzadeh, M. K., Lentine, K., & Singh, N. (2026). WHO Guideline on GLP-1 Therapies for Treatment of Obesity in Adults. JAMA, 335(16), 1450. https://doi.org/10.1001/jama.2026.0678
Vancouver
Fallahzadeh MK, Lentine K, Singh N. WHO Guideline on GLP-1 Therapies for Treatment of Obesity in Adults. JAMA. 2026;335(16):1450. doi:10.1001/jama.2026.0678
BibTeX
@article{Fallahzadeh2026,
author = {Fallahzadeh, Mohammad Kazem and Lentine, Krista and Singh, Neeraj},
title = {WHO Guideline on GLP-1 Therapies for Treatment of Obesity in Adults},
journal = {JAMA},
year = {2026},
volume = {335},
number = {16},
pages = {1450},
doi = {10.1001/jama.2026.0678}
}
EUVIMED